Final Phase 2 Data Continue to Show Promising Results after One Year of Aranesp(R) Treatment for Anemia in Patients with Myelodysplastic Syndromes (MDS) Read more about Final Phase 2 Data Continue to Show Promising Results after One Year of Aranesp(R) Treatment for Anemia in Patients with Myelodysplastic Syndromes (MDS)
New Phase 2 Data Show Promise of Aranesp(R) Treatment for Anemia of Cancer Read more about New Phase 2 Data Show Promise of Aranesp(R) Treatment for Anemia of Cancer
Data Show Efficacy of Extended Dosing of Aranesp(R) in the Treatment of Chemotherapy-Induced Anemia Read more about Data Show Efficacy of Extended Dosing of Aranesp(R) in the Treatment of Chemotherapy-Induced Anemia
Amgen Submits Testimony to House Ways & Means Committee Read more about Amgen Submits Testimony to House Ways & Means Committee
Amgen Responds to Reports About Use and Safety of EPOGEN and Aranesp in CKD Anemia Therapy Read more about Amgen Responds to Reports About Use and Safety of EPOGEN and Aranesp in CKD Anemia Therapy
Amgen Names Yuji Orihara President, Amgen KK Read more about Amgen Names Yuji Orihara President, Amgen KK
Colorectal Patients Offered New Resource to Help Navigate Treatment Process Read more about Colorectal Patients Offered New Resource to Help Navigate Treatment Process
District Court Judge Denies Preliminary Injunction in Ortho v. Amgen Suit Read more about District Court Judge Denies Preliminary Injunction in Ortho v. Amgen Suit
Fashion Designer and Cancer Survivor Carmen Marc Valvo Offers Support Read more about Fashion Designer and Cancer Survivor Carmen Marc Valvo Offers Support
Amgen Launches ChemoCoach.com and ``My Cancer Coach'' Contest in Conjunction with Sponsorship of College Hoops Classic Benefiting Coaches vs. Cancer Read more about Amgen Launches ChemoCoach.com and ``My Cancer Coach'' Contest in Conjunction with Sponsorship of College Hoops Classic Benefiting Coaches vs. Cancer
